A5089803294- Pharmaceutical Practices and Patient Outcomes
- Pharmaceutical Economics and Policy
- Pharmaceutical studies and practices
- Health Systems, Economic Evaluations, Quality of Life
- Pharmaceutical industry and healthcare
- Safe Handling of Antineoplastic Drugs
- Biomedical Ethics and Regulation
- Intravenous Infusion Technology and Safety
- Health Sciences Research and Education
- Patient Safety and Medication Errors
- Streptococcal Infections and Treatments
- Lipoproteins and Cardiovascular Health
- Pneumonia and Respiratory Infections
- Ethics in Clinical Research
- Opioid Use Disorder Treatment
- Hemostasis and retained surgical items
- Hemophilia Treatment and Research
- Poisoning and overdose treatments
- Glioma Diagnosis and Treatment
- Maternal and fetal healthcare
- Brain Metastases and Treatment
- Blood Coagulation and Thrombosis Mechanisms
- Maternal and Perinatal Health Interventions
- Antibiotics Pharmacokinetics and Efficacy
- Medication Adherence and Compliance
University of Illinois Chicago
2013-2022
American College of Clinical Pharmacy
2016
University of Illinois Urbana-Champaign
2006-2012
Nova Southeastern University
2011
Miami Children's Hospital
2011
University of Miami
2011
IS practice
2001
The provision of drug information (DI) is among the fundamental professional responsibilities all pharmacists. Recent practice trends, including increased medication therapy management services and efforts to obtain provider status, have placed pharmacists in increasingly complex
he Federal Comprehensive Drug Abuse Prevention and Control Act of 1970, more commonly known as the Controlled Substances Act, became effective on May 1, 1971. 1,2This federal law contains 3 different titles.Title I deals with establishment rehabilitation programs for drug abusers, Title II addresses registration distribution controlled substances, III discusses issues related to importation exportation substances. 2 The main segment interest pharmacists is II.This RxLegal column first a...
Intravenous (IV) push administration can provide clinical and practical advantages over longer IV infusions in multiple scenarios, including the emergency department, fluid-restricted patients, when supplies of diluents are limited. In these settings, conversion to may a solution. This review compiles available data on antibiotics adults, preparation, stability, instructions. Prescribing information, tertiary drug resources, primary literature were consulted compile relevant data. Several...
These guidelines describe essential elements of the medication-use evaluation (MUE) process for healthcare organizations. include goals and objectives a MUE, performance improvement methods, description indicators suggesting need an how to prioritize select medications processes evaluation, typical steps in process, roles responsibilities interdisciplinary team, common problems pitfalls, useful resources. MUE is systematic method with overarching goal optimizing patient outcomes via ongoing...
The drug information curriculum in US colleges of pharmacy continues to evolve. American College Clinical Pharmacy (ACCP) Drug Information Practice and Research Network (DI PRN) published an opinion paper with specific recommendations regarding education 2009. Adoption these has not been evaluated.To assess which made the ACCP DI PRN are included school curricula characterize faculty qualifications, educational methods, recent changes education.An electronic survey was designed using...
A national spotlight was shone on the safety of compounded pharmaceutical products with 2012 multistate outbreak fungal meningitis and other infections due to contaminated steroid injections produced by New England Compounding Center (NECC) in Framingham, Massachusetts.1 To date, 751 cases 64 deaths 20 states have been linked tainted NECC injections. As a direct result this outbreak, Congress passed Drug Quality Security Act, which signed into law President Obama November 2013.2–4 The Act...
The American College of Clinical Pharmacy ( ACCP ) published an initial white paper on herbal products in 2000. Since then, the global market for natural has continued to expand, with tens millions consumers using such annual basis United States alone. However, despite this expansion, remain largely unregulated compared prescription medications, have moderate‐ low‐level clinical evidence efficacy, and continue safety concerns, including adulteration misbranding. As comprehensive medication...
According to the Centers for Disease Control and Prevention (CDC), more than 36,000 individuals were victims of a fatal drug overdose in 2008.1 The majority these deaths related prescription abuse, most frequently opioid analgesics. Multiple factors have contributed severity abuse misuse United States, including substantial increase number prescriptions dispensed by retail pharmacists (from an estimated 76 million 1991 over 200 from 2009 2013), social acceptability administering medications...
The Centers for Medicare and Medicaid Services (CMS) initially created direct indirect remuneration (DIR) fees with the enactment of Part D in order to track rebates other price adjustments made pharmacy benefit managers (PBMs). PBMs have expanded use these "claw back" money from pharmacies on already dispensed medications. Community specialty claim are not transparent, hurt patients taxpayers, negatively impact their fiscal bottom line, while assert that actually reduce premiums patients....
The etiology of Kawasaki disease remains unknown despite extensive studies. Some researchers suggest that it is caused by an infectious agent. This a case report where patient with incomplete was found to have evidence compatible acute Mycoplasma pneumoniae infection. one the several reports linking as possible trigger. perhaps due superantigen or mediated some other mechanism. Accurate and timely testing for infections difficult has its limitations. Despite this, should be considered in...